8
Cat No. | Product Name | Synonyms | Targets |
---|---|---|---|
T7396 | Substance P(1-7) | Substance P 1-7 | Others , Neurokinin receptor |
Substance P(1-7) (Substance P 1-7) is the major bioactive metabolite formed after proteolytic degradation of the tachykinin substance P (SP),with anti-inflammatory, anti-nociceptive and anti-hyperalgesic effects | |||
T7675 | Substance P (1-7) 2TFA(68060-49-1(free base)) | Others | |
Substance P (1-7) 2TFA(68060-49-1(free base)) is the major bioactive metabolite formed after proteolytic degradation of the tachykinin substance P (SP),with anti-inflammatory, anti-nociceptive and anti-hyperalgesic effec... | |||
TP1034 | Substance P (1-7)(TFA) (68060-49-1 free base) | Substance P (1-7) Trifluoroacetate,Substance P (1-7)(TFA) | |
Substance P (1-7)(TFA) is a fragment of the neuropeptide, substance P (SP). | |||
T75963 | Substance P(1-7) TFA | ||
Substance P(1-7) TFA, a fragment of the neuropeptide substance P (SP), induces depressor and bradycardic effects upon application to the nucleus tractus solitarius [1]. | |||
TP1862L | [Sar9] Substance P acetate(77128-75-7 free base) | Neurokinin receptor | |
[Sar9]-Substance P acetate is one of NK-1 receptor agonist. The action of SP on progesterone metabolism was mimicked by the rNK1-specific agonist [Sar-9,Met(O2)11]-SP. | |||
TP1899L1 | Hemokinin 1 (human) acetate(491851-53-7 free base) | Neurokinin receptor | |
Hemokinin 1 (human) acetate is an endogenous substance P homolog that is a selective agonist at the tachykinin NK1 receptor (IC50 values are 1.8, 370 and 480 nM for NK1, NK3 and NK2 receptors respectively). Has prolifera... | |||
TP1054 | PACAP (1-38), human, ovine, rat TFA | Pituitary Adenylate Cyclase Activating Polypeptide 38 (TFA) | |
PACAP (1-38), a novel neuropeptide isolated from the bovine hypothalamus is more active than vasoactive intestinal peptide (VIP) in stimulating adenylate cyclase (EC50=7 nM). PACAP 1-38 (10-9 M) increased substance P (SP... | |||
T29186 | YM49598 | YM-49598,YM 49598 | |
YM49598 is a tachykinin receptor antagonist. YM49598 exhibited high binding affinities at NK(1) (pK(i) = 9.09 +/- 0.02) and NK(2) (pK(i) = 9.94 +/- 0.03) receptors, respectively. YM49598 was almost inactive but produced ... |